Shaun Holt
CEO
Alveo is a pre-clinical stage medical diagnostics company focused on developing novel biomarker assays for early disease detection. Their technology aims to improve diagnostic accuracy and speed, addressing the critical need for timely interventions in patient care.
Funding not disclosed


CEO